A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
179 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Neurocentrix
Carlton, Australia
David BartonRecruiting - Lyell Mcewin Hospital
Elizabeth Vale, Australia
Dennis LiuNot, yet, recruiting - Barwon Health
Geelong, Australia
Roth TrisnoRecruiting - Multidisciplinary Alfred Psychiatry Research Centre
Melbourne, Australia
Rebecca HoRecruiting - Paratus Clinical Research - Melbourne
Melbourne, Australia
Paul FitzgeraldRecruiting - Toowoomba Hospital
Toowoomba, Australia
Vikas GargRecruiting - Westmead Hospital
Westmead, Australia
Vlasios BrakouliasRecruiting
- Hospital Das Clínicas Da Ufmg
Belo Horizonte, Brazil
Frederico GarciaNot, yet, recruiting - Trial Tech
Curitiba, Brazil
Hamilton GrabowskiRecruiting - Clinilive
Maringá, Brazil
Antonio da SilvaRecruiting - Centro de Pesquisa Clínica de Marília - Cpclim
Marília, Brazil
Fernanda GuimarãesRecruiting - Hospital Universitário Onofre Lopes
Natal, Brazil
Walter SoaresRecruiting - Ruschel Medicina E Pesquisa Clínica
Rio de Janeiro, Brazil
Sandra RuschelRecruiting - Facili Centro Integrado de Psiquiatria
São Bernardo do Campo, Brazil
Cintia de Azevedo Marques PéricoRecruiting - Br Trials - Ensaios Clinicos E Consultoria
São Paulo, Brazil
Acioly LacerdaRecruiting - Cpclin
São Paulo, Brazil
Denise FrancoNot, yet, recruiting - Cpquali Pesquisa Clínica
São Paulo, Brazil
Moacyr RosaRecruiting - A2z Clinical Centro Avançado de Pesquisa Clínica - Valinhos
Valinhos, Brazil
Caroline da SilvaRecruiting
- Heritage Medical Research Clinic
Calgary, Canada
Thomas RaedlerNot, yet, recruiting - Premier Clinical Trial Network
Hamilton, Canada
Richard TytusNot, yet, recruiting - Kelowna Health and Memory Centre
Kelowna, Canada
Eugene OkorieNot, yet, recruiting - Alpha Recherche Clinique - Lévis
Lévis, Canada
Julie BeaudoinRecruiting - Genge Partners
Montreal, Canada
Simon DucharmeNot, yet, recruiting - Dar Clinical Research - Ottawa
Ottawa, Canada
Jabir JassamRecruiting - Alpha Recherche Clinique
Québec, Canada
Jérôme NadeauRecruiting - Alpha Recherche Clinique
Québec, Canada
Raphael Poulin-RobitailleRecruiting - Centre de Recherche Saint-Louis Inc.
Québec, Canada
Catherine VaillancourtNot, yet, recruiting - Richmond Clinical Trials
Richmond, Canada
Harris LariRecruiting - Bluewater Clinical Research Group Inc.
Sarnia, Canada
John O'MahonyNot, yet, recruiting - Diex Recherche Sherbrooke
Sherbrooke, Canada
Suspended - Centre for Neurology Studies
Surrey, Canada
Shimi KangNot, yet, recruiting - Maple Leaf Research
Toronto, Canada
Suspended
- Beijing Anding Hospital - Affiliated Capital University of Medical Science
Beijing, China
Gang WangRecruiting - Beijing Huilongguan Hospital
Beijing, China
Yunlong TanRecruiting - the Second People'S Hospital of Hunan Province
Changsha, China
Xuhui ZhouRecruiting - the Fourth People'S Hospital of Chengdu
Chengdu, China
Feiyan WangRecruiting - Guangzhou Brain Hospital
Guangzhou, China
Yuping NingRecruiting - Peking University Sixth Hospital
Haidian District, China
Hongyan ZhangRecruiting - Hefei No.4 People'S Hospital
Hefei, China
Jianliang GaoRecruiting - 3rd People'S Hospital of Huzhou
Huzhou, China
Jianjun LiuRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Feb 2026
- Primary completion
- 29 Feb 2028
- Completion
- 29 Feb 2028
- Last update posted
- 6 Aug 2026
- Registered enrollment
- 1,000
- Registry id
- NCT07412756
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.